Adriano Duatti
Overview
Explore the profile of Adriano Duatti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutfilen B, Duatti A
Front Med (Lausanne)
. 2023 Dec;
10:1334294.
PMID: 38076256
No abstract available.
2.
DaSilva J, Decristoforo C, Mach R, Bormans G, Carlucci G, Al-Qahtani M, et al.
EJNMMI Radiopharm Chem
. 2023 Oct;
8(1):35.
PMID: 37889361
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This selection...
3.
Duatti A
EJNMMI Radiopharm Chem
. 2023 Aug;
8(1):17.
PMID: 37535275
Background: The hypothetical concept of 'macrocyclic cavity' is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (HDOTA). It Is...
4.
Kleynhans J, Duatti A, Bolzati C
Molecules
. 2023 Feb;
28(3).
PMID: 36771153
The β emitter, rhenium-188 (Re), has long been recognized as an attractive candidate for targeted cancer radionuclide therapy (TRNT). This transition metal shares chemical similarities with its congener element technetium,...
5.
Toyohara J, Al-Qahtani M, Huang Y, Cazzola E, Todde S, Furumoto S, et al.
EJNMMI Radiopharm Chem
. 2022 Oct;
7(1):25.
PMID: 36182995
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary...
6.
Kleynhans J, Duatti A
EJNMMI Radiopharm Chem
. 2022 Sep;
7(1):23.
PMID: 36068452
No abstract available.
7.
Jalilian A, Ocampo-Garcia B, Pasanphan W, Sakr T, Melendez-Alafort L, Grasselli M, et al.
Pharmaceutics
. 2022 May;
14(5).
PMID: 35631646
The rapidly growing interest in the application of nanoscience in the future design of radiopharmaceuticals and the development of nanosized radiopharmaceuticals in the late 2000's, resulted in the creation of...
8.
Martini P, Boschi A, Marvelli L, Uccelli L, Carli S, Cruciani G, et al.
Molecules
. 2021 Oct;
26(19).
PMID: 34641499
(1) Background: Metal dithiocarbamate compounds have long been the subject of research due to their ease of formation, excellent properties and potential applications. However, manganese complexes with dithiocarbamates, to our...
9.
Martini P, Uccelli L, Duatti A, Marvelli L, Esposito J, Boschi A
Molecules
. 2021 Sep;
26(18).
PMID: 34577170
The trend to achieve even more compact-sized systems is leading to the development of micro-scale reactors (lab-on-chip) in the field of radiochemical separation and radiopharmaceutical production. Technetium-99m extraction from both...
10.
Aime S, Al-Qahtani M, Behe M, Bormans G, Carlucci G, DaSilva J, et al.
EJNMMI Radiopharm Chem
. 2021 Mar;
6(1):13.
PMID: 33738618
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of...